Long-Term Risk of Progression to Sustained Hypertension in White-Coat Hypertension with Normal Night-Time Blood Pressure Values

Table 1

Anthropometric biochemical data at baseline.

	NT (n = 434)	WCHT untreated (n = 399)	WCHT treated (n = 156)	=
Age (years)	49 ± 14	51 ± 14	51 ± 15	0.011
Female (%)	52.9	51.1	52.4	0.665
BMI (Kg/m^2)	27 ± 3	26 ± 4	26 ± 4	0.229
Smoking (%)	18	16	14	0.564
Glucose (mg/dl)	91 ± 022	97 ± 28	98 ± 25	0.171
Creatinine (mg/dl)	1.06 ± 0.27	0.99 ± 0.31	1.03 ± 0.40	0.783
Sodium (mEq/L)	139 ± 2	140 ± 3	140 ± 2	0.123
Potassium (mEq/L)	4.4 ± 0.8	4.3 ± 0.5	4.5 ± 0.10	0.160
Uric acid (mg/ml)	4.9 ± 1.4	5.2 ± 1.6	5.4 ± 1.7	0.021
Total cholesterol (mg/dl)	197 ± 35	199 ± 38	204 ± 39	0.259
HDL-C (mg/dl)	56 ± 14	56 ± 15	56 ± 16	0.864
LDL-C (mg/dl)	118 ± 33	119 ± 34	121 ± 34	0.320
Triglycerides (mg/dl)	117 ± 44	122 ± 49	121 ± 45	0.793
Albuminuria (mg/24 h)	31 ± 17	32 ± 21	29 ± 20	0.546

NT, normotensives; WCHT, white-coat hypertensives; BMI, body mass index. Post hoc analysis: vs. NT and WCHT treated; vs. NT.